November 20, 2018: Most content in the UA Campus Repository is not accessible using the search/browse functions due to a performance bug; we are actively working to resolve this issue. If you are looking for content you know is in the repository, but cannot get to it, please email us at email@example.com with your questions and we'll make sure to get the content to you.
A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy
AuthorStern, Joshua A.
Kim, Jae B.
Pascoe, Peter J.
Evanchik, Marc J.
Green, Eric M.
Harris, Samantha P.
AffiliationUniv Arizona, Coll Med, Dept Cellular & Mol Med
MetadataShow full item record
PublisherPUBLIC LIBRARY SCIENCE
CitationA Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy 2016, 11 (12):e0168407 PLOS ONE
Rights© 2016 Stern et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractHypertrophic cardiomyopathy (HCM) is an inherited disease of the heart muscle characterized by otherwise unexplained thickening of the left ventricle. Left ventricular outflow tract (LVOT) obstruction is present in approximately two-thirds of patients and substantially increases the risk of disease complications. Invasive treatment with septal myectomy or alcohol septal ablation can improve symptoms and functional status, but currently available drugs for reducing obstruction have pleiotropic effects and variable therapeutic responses. New medical treatments with more targeted pharmacology are needed, but the lack of preclinical animal models for HCM with LVOT obstruction has limited their development. HCM is a common cause of heart failure in cats, and a subset exhibit systolic anterior motion of the mitral valve leading to LVOT obstruction. MYK-461 is a recently-described, mechanistically novel small molecule that acts at the sarcomere to specifically inhibit contractility that has been proposed as a treatment for HCM. Here, we use MYK-461 to test whether direct reduction in contractility is sufficient to relieve LVOT obstruction in feline HCM. We evaluated mixed-breed cats in a research colony derived from a Maine Coon/mixed-breed founder with naturally-occurring HCM. By echocardiography, we identified five cats that developed systolic anterior motion of the mitral valve and LVOT obstruction both at rest and under anesthesia when provoked with an adrenergic agonist. An IV MYK-461 infusion and echocardiography protocol was developed to serially assess contractility and LVOT gradient at multiple MYK-461 concentrations. Treatment with MYK-461 reduced contractility, eliminated systolic anterior motion of the mitral valve and relieved LVOT pressure gradients in an exposure-dependent manner. Our findings provide proof of principle that acute reduction in contractility with MYK-461 is sufficient to relieve LVOT obstruction. Further, these studies suggest that feline HCM will be a valuable translational model for the study of disease pathology, particularly LVOT obstruction.
NoteOpen Access Journal.
VersionFinal published version
- Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
- Authors: Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M, Agler D, Lytle BW, Lever HM, Desai MY
- Issue date: 2015 Jul
- Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
- Authors: Lafitte S, Reant P, Touche C, Pillois X, Dijos M, Arsac F, Peyrou J, Montaudon M, Ritter P, Roudaut R, Demaria A
- Issue date: 2013 Aug 27
- Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
- Authors: Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D
- Issue date: 1994 Dec
- Patterns of cardiac dysfunction coinciding with exertional breathlessness in hypertrophic cardiomyopathy.
- Authors: Maras D, Chung R, Duncan A, Li W, Thorp C, Mörner S, Lindqvist P, Henein MY
- Issue date: 2013 Dec 10
- Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.
- Authors: Hong J, Schaff HV, Ommen SR, Abel MD, Dearani JA, Nishimura RA
- Issue date: 2016 Apr